Turning an ‘Achilles’ Heel’ into an asset – activation of HIF-1α during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damage

This publication has 12 references indexed in Scilit:

• Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells
  Life Sciences, 2001
• The von Hippel–Lindau Tumor Suppressor Gene
  Experimental Cell Research, 2001
• Regulation of Mammalian O₂Homeostasis by Hypoxia-Inducible Factor 1
  Annual Review of Cell and Developmental Biology, 1999
• HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation
  Nucleic Acids Research, 1999
• The transferrin receptor: role in health and disease
  The International Journal of Biochemistry & Cell Biology, 1999
• Identification of a Hypoxia Response Element in the Transferrin Receptor Gene
  Journal of Biological Chemistry, 1999
• The mode of action of the antimalarial artemisinin and its derivatives
  General Pharmacology: The Vascular System, 1996
• Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat
  Cancer Letters, 1995
• Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin
  Cancer Letters, 1995
• Breast Carcinoma and the Role of Iron Metabolism
  Annals of the New York Academy of Sciences, 1993